Cell Death Discovery · 2021 · 14 citations · 21 references
Life SciencesOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsCytotoxic ChemotherapyIntrinsic Apoptotic PathwayApoptosis Signaling In CancerApoptosis TargetingApoptotic ResponseBcl-xl FunctionBh3-only Protein FunctionChemotherapy-induced ApoptosisOsteosarcoma ChemotherapyOsteosarcoma Treatment
Apoptosis induced by doxorubicin, bortezomib, or paclitaxel, targeting DNA, 26S proteasome, and microtubules respectively, was assessed in two osteosarcoma cells, p53 wild-type U2OS and p53-null MG63 cells. Doxorubicin-induced apoptosis only occurred in U2OS, not in MG63. In contrast, bortezomib and paclitaxel could drive U2OS or MG63 toward apoptosis effectively, suggesting that apoptosis induced by bortezomib or paclitaxel is p53-independent. The expressions of Bcl2 family members such as Bcl2, Bcl-xl, and Puma could be seen in U2OS and MG63 cells with or without doxorubicin, bortezomib, or paclitaxel treatment. In contrast, another member, Bim, only could be observed in U2OS, not in MG63, under the same conditions. Bim knockdown did not affect the doxorubicin-induced apoptosis in U2OS, suggested that a BH3-only protein other than Bim might participate in apoptosis induced by doxorubicin. Using a BH3-mimetic, ABT-263, to inhibit Bcl2 or Bcl-xl produced a limited apoptotic response in U2OS and MG63 cells, suggesting that this BH3-mimetic cannot activate the Bax/Bak pathway efficiently. Significantly, ABT-263 enhanced doxorubicin- and bortezomib-induced apoptosis synergistically in U2OS and MG63 cells. These results implied that the severe cellular stress caused by doxorubicin or bortezomib might be mediated through a dual process to control apoptosis. Respectively, doxorubicin or bortezomib activates a BH3-only protein in one way and corresponding unknown factors in another way to affect mitochondrial outer membrane permeability, resulting in apoptosis. The combination of doxorubicin with ABT-263 could produce synergistic apoptosis in MG63 cells, which lack p53, suggesting that p53 has no role in doxorubicin-induced apoptosis in osteosarcoma. In addition, ABT-263 enhanced paclitaxel to induce moderate levels of apoptosis.
21
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Katsunori Nakano, Karen H. Vousden · Molecular Cell · 2001 · 2.3K citations · Full text
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Eri Oda, Rieko Ohki, Hideki Murasawa et al. · Science · 2000 · 2.1K citations
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen, Armita Bahrami, Alberto S. Pappo et al. · Cell Reports · 2014 · 760 citations · Full text
Life Sciences, Genetics, Oncology +17